Stabilizing membrane proteins through protein engineering

Current Opinion in Chemical Biology

Volumn 17, Issue 3, 2013, Pages 427-435

  Scott, Daniel J ^a   Kummer, Lutz ^b   Tremmel, Dirk ^b   Plückthun, Andreas ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; MEMBRANE PROTEIN;

ESCHERICHIA COLI; HIGH THROUGHPUT SCREENING; MICELLE; MUTAGENESIS; MUTATION; PROTEIN DATA BANK; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN STABILITY; REVIEW;

DIRECTED MOLECULAR EVOLUTION; HUMANS; MEMBRANE PROTEINS; MUTAGENESIS; PROTEIN ENGINEERING; PROTEIN STABILITY; SOLUBILITY;

EID: 84878848170     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2013.04.002     Document Type: Review

References (54)

1. Ahram M., Litou Z.I., Fang R., Al-Tawallbeh G. Estimation of membrane proteins in the human proteome. In Silico Biol 2006, 6:379-386.
2. Bowie J.U. Stabilizing membrane proteins. Curr Opin Struct Biol 2001, 11:397-402.
3. Prive G.G. Detergents for the stabilization and crystallization of membrane proteins. Methods 2007, 41:388-397.
4. Chae P.S., Rasmussen S.G., Rana R.R., Gotfryd K., Chandra R., Goren M.A., Kruse A.C., Nurva S., Loland C.J., Pierre Y., et al. Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat Methods 2010, 7:1003-1008.
5. Arachea B.T., Sun Z., Potente N., Malik R., Isailovic D., Viola R.E. Detergent selection for enhanced extraction of membrane proteins. Protein Expr Purif 2012, 86:12-20.
6. Oberai A., Ihm Y., Kim S., Bowie J.U. A limited universe of membrane protein families and folds. Protein Sci 2006, 15:1723-1734.
7. Ubarretxena-Belandia I., Engelman D.M. Helical membrane proteins: diversity of functions in the context of simple architecture. Curr Opin Struct Biol 2001, 11:370-376.
8. Liu Y., Gerstein M., Engelman D.M. Transmembrane protein domains rarely use covalent domain recombination as an evolutionary mechanism. Proc Natl Acad Sci U S A 2004, 101:3495-3497.
9. Rompler H., Staubert C., Thor D., Schulz A., Hofreiter M., Schoneberg T. G protein-coupled time travel: evolutionary aspects of GPCR research. Mol Interventions 2007, 7:17-25.
10. Schoneberg T., Hofreiter M., Schulz A., Rompler H. Learning from the past: evolution of GPCR functions. Trends Pharmacol Sci 2007, 28:117-121.
11. Van Horn W.D., Kim H.J., Ellis C.D., Hadziselimovic A., Sulistijo E.S., Karra M.D., Tian C., Sonnichsen F.D., Sanders C.R. Solution nuclear magnetic resonance structure of membrane-integral diacylglycerol kinase. Science 2009, 324:1726-1729.
12. Wen J., Chen X., Bowie J.U. Exploring the allowed sequence space of a membrane protein. Nat Struct Biol 1996, 3:141-148.
13. Lau F.W., Nauli S., Zhou Y., Bowie J.U. Changing single side-chains can greatly enhance the resistance of a membrane protein to irreversible inactivation. J Mol Biol 1999, 290:559-564.
14. Zhou Y., Bowie J.U. Building a thermostable membrane protein. J Biol Chem 2000, 275:6975-6979.
15. Xie G., Gross A.K., Oprian D.D. An opsin mutant with increased thermal stability. Biochemistry 2003, 42:1995-2001.
16. Standfuss J., Xie G., Edwards P.C., Burghammer M., Oprian D.D., Schertler G.F. Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol 2007, 372:1179-1188.
17. Faham S., Yang D., Bare E., Yohannan S., Whitelegge J.P., Bowie J.U. Side-chain contributions to membrane protein structure and stability. J Mol Biol 2004, 335:297-305.
18. Magnani F., Shibata Y., Serrano-Vega M.J., Tate C.G. Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor. Proc Natl Acad Sci U S A 2008, 105:10744-10749.
19. Serrano-Vega M.J., Magnani F., Shibata Y., Tate C.G. Conformational thermostabilization of the beta1-adrenergic receptor in a detergent-resistant form. Proc Natl Acad Sci U S A 2008, 105:877-882.
20. Shibata Y., White J.F., Serrano-Vega M.J., Magnani F., Aloia A.L., Grisshammer R., Tate C.G. Thermostabilization of the neurotensin receptor NTS1. J Mol Biol 2009, 390:262-277.
21. Miller J.L., Tate C.G. Engineering an ultra-thermostable beta(1)-adrenoceptor. J Mol Biol 2011, 413:628-638.
22. Robertson N., Jazayeri A., Errey J., Baig A., Hurrell E., Zhukov A., Langmead C.J., Weir M., Marshall F.H. The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery. Neuropharmacology 2011, 60:36-44.
23. Congreve M., Langmead C.J., Mason J.S., Marshall F.H. Progress in structure based drug design for G protein-coupled receptors. J Med Chem 2011, 54:4283-4311.
24. Zhukov A., Andrews S.P., Errey J.C., Robertson N., Tehan B., Mason J.S., Marshall F.H., Weir M., Congreve M. Biophysical mapping of the adenosine A2A receptor. J Med Chem 2011, 54:4312-4323.
25. Warne T., Serrano-Vega M.J., Baker J.G., Moukhametzianov R., Edwards P.C., Henderson R., Leslie A.G., Tate C.G., Schertler G.F. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454:486-491.
26. Dore A.S., Robertson N., Errey J.C., Ng I., Hollenstein K., Tehan B., Hurrell E., Bennett K., Congreve M., Magnani F., et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 2011, 19:1283-1293.
27. Lebon G., Warne T., Edwards P.C., Bennett K., Langmead C.J., Leslie A.G., Tate C.G. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature 2011, 474:521-525.
28. Moukhametzianov R., Warne T., Edwards P.C., Serrano-Vega M.J., Leslie A.G., Tate C.G., Schertler G.F. Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor. Proc Natl Acad Sci U S A 2011, 108:8228-8232.
29. Warne T., Moukhametzianov R., Baker J.G., Nehme R., Edwards P.C., Leslie A.G., Schertler G.F., Tate C.G. The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature 2011, 469:241-244.
30. White J.F., Noinaj N., Shibata Y., Love J., Kloss B., Xu F., Gvozdenovic-Jeremic J., Shah P., Shiloach J., Tate C.G., et al. Structure of the agonist-bound neurotensin receptor. Nature 2012, 490:508-513.
31. Rosenbaum D.M., Cherezov V., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Yao X.J., Weis W.I., Stevens R.C., et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007, 318:1266-1273.
32. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
33. Hanson M.A., Cherezov V., Griffith M.T., Roth C.B., Jaakola V.P., Chien E.Y., Velasquez J., Kuhn P., Stevens R.C. A specific cholesterol binding site is established by the 2.8Å structure of the human beta2-adrenergic receptor. Structure 2008, 16:897-905.
34. Jaakola V.P., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y., Lane J.R., Ijzerman A.P., Stevens R.C. The 2.6Ångström crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008, 322:1211-1217.
35. Chien E.Y., Liu W., Zhao Q., Katritch V., Han G.W., Hanson M.A., Shi L., Newman A.H., Javitch J.A., Cherezov V., et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010, 330:1091-1095.
36. Wu B., Chien E.Y., Mol C.D., Fenalti G., Liu W., Katritch V., Abagyan R., Brooun A., Wells P., Bi F.C., et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330:1066-1071.
37. Shimamura T., Shiroishi M., Weyand S., Tsujimoto H., Winter G., Katritch V., Abagyan R., Cherezov V., Liu W., Han G.W., et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011, 475:65-70.
38. Xu F., Wu H., Katritch V., Han G.W., Jacobson K.A., Gao Z.G., Cherezov V., Stevens R.C. Structure of an agonist-bound human A2A adenosine receptor. Science 2011, 332:322-327.
39. Wu H., Wacker D., Mileni M., Katritch V., Han G.W., Vardy E., Liu W., Thompson A.A., Huang X.P., Carroll F.I., et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature 2012, 485:327-332.
40. Chun E., Thompson A.A., Liu W., Roth C.B., Griffith M.T., Katritch V., Kunken J., Xu F., Cherezov V., Hanson M.A., et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 2012, 20:967-976.
41. Hanson M.A., Roth C.B., Jo E., Griffith M.T., Scott F.L., Reinhart G., Desale H., Clemons B., Cahalan S.M., Schuerer S.C., et al. Crystal structure of a lipid G protein-coupled receptor. Science 2012, 335:851-855.
42. Manglik A., Kruse A.C., Kobilka T.S., Thian F.S., Mathiesen J.M., Sunahara R.K., Pardo L., Weis W.I., Kobilka B.K., Granier S. Crystal structure of the mu-opioid receptor bound to a morphinan antagonist. Nature 2012, 485:321-326.
43. Li S.C., Deber C.M. A measure of helical propensity for amino acids in membrane environments. Nat Struct Biol 1994, 1:368-373.
44. Grisshammer R., Duckworth R., Henderson R. Expression of a rat neurotensin receptor in Escherichia coli. Biochem J 1993, 295:571-576.
45. Sarkar C.A., Dodevski I., Kenig M., Dudli S., Mohr A., Hermans E., Plückthun A. Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity. Proc Natl Acad Sci U S A 2008, 105:14808-14813.
46. Dodevski I., Plückthun A. Evolution of three human GPCRs for higher expression and stability. J Mol Biol 2011, 408:599-615.
47. Schlinkmann K.M., Honegger A., Türeci E., Robison K.E., Lipovsek D., Plückthun A. Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations. Proc Natl Acad Sci U S A 2012, 109:9810-9815.
48. Schlinkmann K.M., Hillenbrand M., Rittner A., Kunz M., Strohner R., Plückthun A. Maximizing detergent stability and functional expression of a GPCR by exhaustive recombination and evolution. J Mol Biol 2012, 422:414-428.
49. Scott D.J., Plückthun A. Direct molecular evolution of detergent-stable G protein-coupled receptors using polymer encapsulated cells. J Mol Biol 2012, 425:662-667.
50. Chen K.Y., Zhou F., Fryszczyn B.G., Barth P. Naturally evolved G protein-coupled receptors adopt metastable conformations. Proc Natl Acad Sci U S A 2012, 109:13284-13289.
51. 2-adrenergic receptor activation. Cell 2013, 152:532-542.
52. Congreve M., Andrews S.P., Dore A.S., Hollenstein K., Hurrell E., Langmead C.J., Mason J.S., Ng I.W., Tehan B., Zhukov A., et al. Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design. J Med Chem 2012, 55:1898-1903.
53. Congreve M., Langmead C., Marshall F.H. The use of GPCR structures in drug design. Adv Pharmacol 2011, 62:1-36.
54. Congreve M., Marshall F. The impact of GPCR structures on pharmacology and structure-based drug design. Br J Pharmacol 2010, 159:986-996.